Brief: Silence Therapeutics And Hansoh Pharma Announces Collaboration
Oct 15 (Reuters) - Silence Therapeutics PLC SLN.L :
* SILENCE THERAPEUTICS - SILENCE AND HANSOH PHARMA ANNOUNCE
COLLABORATION
* SILENCE THERAPEUTICS PLC- HANSOH WILL MAKE A $16 MILLION
UPFRONT
CASH PAYMENT AND SILENCE HAS POTENTIAL TO RECEIVE UP TO $1.3
BILLION IN MILESTONES
* SILENCE THERAPEUTICS PLC- GAINS EXCLUSIVE RIGHTS TO TWO
TARGETS
IN ALL TERRITORIES EXCEPT CHINA REGION
* SILENCE THERAPEUTICS PLC- ANNOUNCED COLLABORATION TO
DEVELOP
SIRNAS FOR 3 UDISCLOSED TARGETS LEVERAGING SILENCE'S PROPRIETARY
MRNAI GOLD PLATFORM
Source text for Eikon: ID:nRSO1618Pa
Further company coverage: SLN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silence Therapeutics
See all newsBrief: Silence Therapeutics Reports Second Quarter 2025 Financial Results And Recent Business Highlights
Brief: Silence Therapeutics files for stock shelf, size not disclosed
Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study
Brief: Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study Of Zerlasiran In Patients With Elevated Lipoprotein
Brief: Silence Therapeutics PLC Files For Resale Of Up To 5.71 Million Shares By The Selling Securityholders - SEC Filing